Document is current
Any future updates will be listed below
-
Authors
Spiegel, Jochen
Cuesta, Sergio Martínez
Adhikari, Santosh
Hänsel-Hertsch, Robert
Tannahill, David
Balasubramanian, Shankar http://orcid.org/0000-0002-0281-5815
-
Funding
Funding for this research was provided by:
Cancer Research UK (C9545/A19836, C9681/A29214)
Welcome Trust (209441/Z/17/Z)
EU H2020 Framework Programme (H2020-MSCA- IF-2016)
- License Information
-
More Information
Article History
Received: 30 September 2020
Accepted: 24 March 2021
First Online: 23 April 2021
Declarations
:
: Not applicable.
: S.B. is a founder and shareholder of Cambridge Epigenetix Ltd.
